Fund Holdings — GILEAD SCIENCES, INC.

Total Portfolio Value
$1.94B
Total Bought
$0
Total Sold
$85.80M
Net Transaction
-$85.80M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ARCUS BIOSCIENCES INC(RCUS)31,424,76031,424,7600427,377748,85238.69%+321,475
ASSEMBLY BIOSCIENCES INC4,505,3914,505,3910115,338153,2287.92%+37,890
KYVERNA THERAPEUTICS INC(KYTX)4,126,1194,126,119024,75738,7862.00%+14,029
XILIO THERAPEUTICS INC(XLO)9,105,4519,105,45107,6735,8290.30%-1,844
LEAP THERAPEUTICS INC(CYPH)5,319,1480-5,319,1482,4150—-2,415
GALAPAGOS NV(LKFT)16,707,47716,707,4770578,747550,61628.45%-28,131
TANGO THERAPEUTICS INC(TNGX)4,854,4430-4,854,44340,7770—-40,777
MERUS N V452,5270-452,52742,6050—-42,605
ARCELLX INC
COMMON STOCK
6,720,8036,720,8030551,778438,19622.64%-113,582
Page 1 of 1